- Covance | Labcorp
BURLINGTON, N C -- (BUSINESS WIRE)--May 28, 2020-- LabCorp® (NYSE: LH), a leading global life sciences company that is deeply integrated in guiding patient care, today announced that Covance, its drug development business, is expanding its technology ecosystem to accelerate the adoption of decentralized clinical trials, often referred to as
- Covance - 派克生物 - 博奥派克
Covance，总部在普林斯顿，新泽西，是世界上最大和最全面的药物开发与服务公司。
- 科文司公司_百度百科
科文司公司（Covance，CVD）主营业务包括为制药企业提供临床试验管理与药物开发服务。 其客户涵盖赛诺菲、礼来制药等企业，主要为其管理临床试验及药物开发环节。
- Covance | Medidata Solutions
Covance is the drug development business for LabCorp, a leading global life sciences company that is deeply integrated in guiding patient care, providing comprehensive clinical laboratory and end-to-end drug development services
- 在华经营20余年，全球CRO“一哥”徕博科分拆临床开发业务分别独立上市 | 前线
全球CRO公司排名第一的徕博科 (Labcorp)宣布将公司全资拥有的临床开发业务 (原科文斯 Covance)分拆给徕博科股东。 徕博科计划在2023年下半年完成剥离计划。 在交易完成后,徕博科预计将继续在纽约证券交易所公开交易,临床发展业务也将被公开上市。
- Covance
Covance与我们的客户携手努力，将当前的医疗保健挑战转化为明日的解决方案。 我们还为化学 农用化学品行业提供实验室测试服务，是毒理学分析服务、中心实验室服务、药物筛选服务的市场领导者和第III期临床试验管理服务的全球顶级提供商。
- Covance Inc. -- Company History
Covance Inc ranks second in size among contract biopharmaceutical research organizations in the United States, providing a wide range of integrated product development services worldwide to the pharmaceutical, biotechnology, and medical device industries
- Covance - 2025 Company Profile Team - Tracxn
Explore Covance's in-depth company profile, including funding details, key investors, competitors, and acquisitions
|